Santhosh Kumar Thatikonda

Santhosh Kumar Thatikonda

Company: Genentech

Job title: Senior Principal Scientist

Bio:

Santhosh Kumar Thatikonda has 17 several years experience in oligonucleotide-based therapeutics and synthetic nucleoside chemistry, including more than a decade in industry. At Genentech, he leads the ASI/siRNA design and synthesis of innovative oligonucleotide platforms and delivery strategies. He authored 14 patents and 40+ publications, and managed extensive external collaborations. His expertise spans from early drug discovery to process development, earning him multiple awards for contributions to nucleic acid-based therapeutics.

Seminars:

Advancing Oligonucleotide Therapeutics Through Innovative Chemistry, Novel siRNA designs for Improved Delivery & Biodistribution 4:30 pm

Engineering next-generation oligonucleotide platforms to overcome delivery barriers, enhance intracellular uptake, and achieve durable therapeutic knockdown Developing innovative chemical modifications to enhance stability, potency, safety and improve the overall therapeutic index of oligonucleotide therapeuticsRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.